Implantable Polymer Composite From Invibio

A provider of biomaterial products for the surgical and medical device markets has released an implantable polymer engineered to deliver strength and performance in high-load applications. Endolign composite is a radiolucent, nonmetallic biomaterial capable of replacing cobalt-chromium alloys, titanium alloys, and stainless steel in many applications that traditionally have employed these or other metals. It features good fatigue behavior, biocompatibility, biostability, and is supported by FDA drug and device master files.

November 19, 2012

1 Min Read
Implantable Polymer Composite From Invibio

A provider of biomaterial products for the surgical and medical device markets has released an implantable polymer engineered to deliver strength and performance in high-load applications. Endolign composite is a radiolucent, nonmetallic biomaterial capable of replacing cobalt-chromium alloys, titanium alloys, and stainless steel in many applications that traditionally have employed these or other metals. It features good fatigue behavior, biocompatibility, biostability, and is supported by FDA drug and device master files. An inherently pure and inert composite made up of continuous carbon fibers in a PEEK-polymer matrix, the material is offered as an option for providing structural support or sustained or cyclic load-bearing capability in applications involving implantation or blood, bone, or tissue contact exceeding 30 days. Applications include such devices as translaminar fixation pins, spinal-fusion cages, bone fracture plates and screws, and intermedullary nails and screws.


Invibio Inc.
West Conshohocken, PA


 

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like